Yuyan Chen
Yuyan Chen
The Children's Hospital at Westmead
Verified email at
Cited by
Cited by
Oncogenic mutations of ALK kinase in neuroblastoma
Y Chen, J Takita, YL Choi, M Kato, M Ohira, M Sanada, L Wang, M Soda, ...
Nature 455 (7215), 971, 2008
Frequent inactivation of A20 in B-cell lymphomas
M Kato, M Sanada, I Kato, Y Sato, J Takita, K Takeuchi, A Niwa, Y Chen, ...
Nature 459 (7247), 712, 2009
Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma
J Takita, HW Yang, YY Chen, R Hanada, K Yamamoto, T Teitz, V Kidd, ...
Oncogene 20 (32), 4424, 2001
Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies
Y Chen, J Takita, M Hiwatari, T Igarashi, R Hanada, A Kikuchi, T Hongo, ...
Genes, Chromosomes and Cancer 45 (6), 583-591, 2006
Tumor protein D52 (TPD52) and cancer—oncogene understudy or understudied oncogene?
JA Byrne, S Frost, Y Chen, RK Bright
Tumor Biology 35 (8), 7369-7382, 2014
Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma
J Okubo, J Takita, Y Chen, K Oki, R Nishimura, M Kato, M Sanada, ...
Oncogene 31 (44), 4667, 2012
Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression
Y Chen, J Takita, M Mizuguchi, K Tanaka, K Ida, K Koh, T Igarashi, ...
Genes, Chromosomes and Cancer 46 (4), 348-358, 2007
TPD52 expression increases neutral lipid storage within cultured cells
A Kamili, N Roslan, S Frost, LC Cantrill, D Wang, A Della-Franca, ...
J Cell Sci 128 (17), 3223-3238, 2015
TPD52 represents a survival factor in ERBB2‐amplified breast cancer cells
N Roslan, I Bièche, RK Bright, R Lidereau, Y Chen, JA Byrne
Molecular carcinogenesis 53 (10), 807-819, 2014
Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastoma
J Takita, Y Chen, J Okubo, M Sanada, M Adachi, K Ohki, R Nishimura, ...
Cancer science 102 (9), 1645-1650, 2011
Tumor protein D52 represents a negative regulator of ATM protein levels
Y Chen, A Kamili, J Hardy, G Groblewski, KK Khanna, J Byrne
Cell Cycle 12 (18), 3083-3097, 2013
Hepatoblastoma in a patient with Sotos syndrome
M Kato, J Takita, K Takahashi, M Mimaki, Y Chen, K Koh, K Ida, A Oka, ...
The Journal of pediatrics 155 (6), 937-939, 2009
Genomic structure and mutational analysis of the human KIF1Bα gene located at 1p36. 2 in neuroblastoma
YY Chen, J Takita, YZ Chen, HW Yang, R Hanada, K Yamamoto, ...
International journal of oncology 23 (3), 737-744, 2003
Identification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screening
H Shahheydari, S Frost, BJ Smith, GE Groblewski, Y Chen, JA Byrne
Molecular biology reports 41 (7), 4565-4572, 2014
Genome‐wide approach to identify second gene targets for malignant rhabdoid tumors using high‐density oligonucleotide microarrays
J Takita, Y Chen, M Kato, K Ohki, Y Sato, S Ohta, K Sugita, R Nishimura, ...
Cancer science 105 (3), 258-264, 2014
Frequent inactivation of A20 through gene mutation in B-cell lymphomas
M Kato, M Sanada, I Kato, Y Sato, J Takita, K Takeuchi, A Niwa, Y Chen, ...
[Rinsho ketsueki] The Japanese journal of clinical hematology 52 (6), 313, 2011
Aberrations of the CHK2 gene are rare in pediatric solid tumors
YY Chen, J Takita, K Tanaka, K Ida, K Koh, T Igarashi, R Hanada, ...
International journal of molecular medicine 16 (1), 85-91, 2005
Challenges in identifying candidate amplification targets in human cancers: chromosome 8q21 as a case study
JA Byrne, Y Chen, N Martin La Rotta, GB Peters
Genes & cancer 3 (2), 87-101, 2012
AML1 mutation and FLT3-internal tandem duplication in leukemia transformed from myelodysplastic syndrome
A Shimada, T Taketani, A Kikuchi, R Hanada, H Arakawa, H Kimura, ...
Journal of pediatric hematology/oncology 29 (9), 666-667, 2007
Aberrations of Genes Regulating NF Kappa B Pathway in B-Cell Malignant Lymphoma.
M Kato, M Sanada, I Kato, Y Sato, J Takita, R Kawahata, K Takeuchi, ...
Blood 114 (22), 971-971, 2009
The system can't perform the operation now. Try again later.
Articles 1–20